There are 749 resources available
208O - Association between kidney function, proteinuria and the risk of kidney cancer: A nationwide cohort study involving 10 million participants
Presenter: Jinsung Park
Session: Mini Oral session - Genitourinary tumours
Resources:
Abstract
209O - A novel risk-based approach simulating oncologic surveillance according to smoking status after radical nephroureterectomy with upper tract urothelial carcinoma
Presenter: Keisuke Shigeta
Session: Mini Oral session - Genitourinary tumours
Resources:
Abstract
Targeted therapy with TRK inhibitors in tumours with NTRK fusion
Presenter: Daniel Shao Weng Tan
Session: Tumour agnostic drug development
Resources:
Slides
Webcast
Precision medicine in cellular therapies: How can we identify patients who would benefit most
Presenter: Alena Gros
Session: Precision immunotherapy
Resources:
Slides
Webcast
New biomarkers for checkpoint inhibitor therapy
Presenter: Jayesh Desai
Session: Precision immunotherapy
Resources:
Slides
Webcast
Localized disease: Retroperitoneal
Presenter: Aisha Miah
Session: The multi-modality approach to sarcomas: Balancing cure and quality of life
Resources:
Slides
Webcast
Locally advanced disease
Presenter: Makoto Endo
Session: The multi-modality approach to sarcomas: Balancing cure and quality of life
Resources:
Slides
Webcast
Multi-focal metastatic
Presenter: Fernando Gracieux Jr.
Session: The multi-modality approach to sarcomas: Balancing cure and quality of life
Resources:
Slides
Webcast
Precision medicine and ESMO Scale for Clinical Actionability of molecular Target (ESCAT) biomarkers
Presenter: Fabrice André
Session: ESMO – CSCO Collaborative Session: Drug prioritisation and support of biomarkers
Resources:
Slides
Webcast
Development of biomarker driven clinical studies in China
Presenter: Xiaotian Zhang
Session: ESMO – CSCO Collaborative Session: Drug prioritisation and support of biomarkers
Resources:
Slides
Webcast